Luteolin and its synthetic derivatives, Lut-C4 and Lut-C6, upregulated the expression of NRF2, SOD1 and GCLC, and improved cell viability in striatal cells from STHdhQ111/Q111 HD transgenic mice [160]. This evidence concerns the gene GCLC and Huntington disease.